http://drsbahl.tripod.com/
FOR YOUR CHRONIC HEALTH PROBLEMS, YOU MAY CONSULT US.
Tuesday, April 21, 2009
Monday, April 06, 2009
SEASONAL ALLERGIES
As all of us are aware that seasonal allergies can be quite trouble some, despite taking the conventional medicines.Homeopathy, on the other hand, is very successful with the treatment of seasonal allergies without the horrendous toll on your system that is generally associated with conventional medicines.
As you are aware, no two cases of seasonal allergies are the same, which is why it is always important to a homeopath how an individual manifests his/her particular symptoms.
We will give a few examples of homeopathic remedies that may help for the most common symptoms of seasonal allergies.
Take one dose every four hours as needed in a 30CH potency.
If after a couple of days, you do not find any noticeable relief, you should try the next remedy that closely matches your individual symptoms or consult a homeopath.
•Allium cepa—This remedy is indicated for symptoms that include watering eyes, runny nose, and frequent sneezing. The discharge from the nose irritates the upper lip. The symptoms usually are worse in a warm stuffy room. Usually the symptoms are better in the open air.
• Arundo mauritanica—Indicated when there is annoying itching in the nostrils and roof of the mouth. Lots of sneezing and itching of nostrils some times accompanied by bluish- coloured phlegm.
• Sabadilla—Indicated when there are red, burning eyelids with a hot face. The person is very sensitive to odors, and the sinuses seem to be the most affected. The symptoms are sometimes better when exposed to a warm wind.
• Wyethia helenoides—Indicated when there is a lot of itching in the throat that extends to the ears. The person seems to be clearing their throat often with constant desire to swallow. There can also be hoarseness associated with the symptoms. Itchiness of the roof of mouth with inclination to rub it with tongue.
Saturday, April 04, 2009
ACE Test
Why get tested?
To help diagnose and monitor sarcoidosis(A chronic disease that causes granulomas and affects organs throughout the body; T lymphocytes and other immune-related cells infiltrate areas and change the structure of surrounding tissues); to help differentiate this systemic condition from other disorders causing similar symptoms
When to get tested?
When you have granulomas(Special form of chronic inflammation; often forms one or more nodules that can involve the skin, lymph nodes, lung, liver, spleen, or other organs. Granulomas often form in response to certain types of infection ,especially to mycobacteria such as in tuberculosis and to fungi or to foreign bodies, but sometimes have no known cause, as in sarcoidosis) that create small bumps under the skin, a lingering cough, red watery eyes, and/or other symptoms suggestive of sarcoidosis; regularly when you have active sarcoidosis to monitor its course
Sample required?
A blood sample drawn from a vein in your arm
To help diagnose and monitor sarcoidosis(A chronic disease that causes granulomas and affects organs throughout the body; T lymphocytes and other immune-related cells infiltrate areas and change the structure of surrounding tissues); to help differentiate this systemic condition from other disorders causing similar symptoms
When to get tested?
When you have granulomas(Special form of chronic inflammation; often forms one or more nodules that can involve the skin, lymph nodes, lung, liver, spleen, or other organs. Granulomas often form in response to certain types of infection ,especially to mycobacteria such as in tuberculosis and to fungi or to foreign bodies, but sometimes have no known cause, as in sarcoidosis) that create small bumps under the skin, a lingering cough, red watery eyes, and/or other symptoms suggestive of sarcoidosis; regularly when you have active sarcoidosis to monitor its course
Sample required?
A blood sample drawn from a vein in your arm
eAG a new term in diabetes control
Diabetics may soon hear a new term and see new numbers that describe how well their disease is being controlled.
That term, “estimated average glucose (eAG),” refers to the result of a diabetic’s glycated hemoglobin (A1c) test, converted into an average blood glucose level in the units of measure seen on glucose meters. Both the American Diabetes Association (ADA) and the American Association for Clinical Chemistry (AACC) hope that using eAG helps patients and their doctors make the necessary changes to diet and physical activity to improve overall diabetes management.
While AACC has called upon laboratories to express A1c results as eAG, it favors a cautious approach to using this new term and number. In a recently released statement, AACC has asked labs to report eAG along with the A1c results patients are used to seeing. The basis of AACC’s position is what it identifies as the need for more data. “At the current time, there is inadequate data to justify sole reporting of eAG without the A1c result,” the statement notes. In particular, AACC calls for further study of whether it’s appropriate to use eAG in certain ethnic groups, pregnant women, and adolescents.
A1c tests, administered during doctor visits, measure average blood glucose control over the previous two to three months. With results stated in percentage points (i.e., A1c of 7%), A1c has long been an important tool in diabetes management. In general, A1c results indicate how successful a patient has been over a period of time in keeping glucose levels in a healthy range through daily self-testing and adjustments to insulin doses.
Diabetics test blood glucose levels several times a day, often before every meal. The readings from self-monitoring help patients fine-tune insulin doses to maintain their glucose levels within an acceptable range. These results are reported in different units than A1c, mg/dl (i.e., 170 mg/dl). Readings from self-monitoring represent the level of glucose in the blood at that moment in time, but do not give any indication of what glucose levels are at other times of day nor what average levels may be over several weeks as do results from the A1c test.
Like A1c, eAG evaluates a patient’s overall success at controlling glucose levels. However, by converting A1c percentage points to the same units as the meters patients use for daily self-monitoring (mg/dl), eAG results have the added advantage of giving physicians and patients a way to correlate A1c results to the daily readings, says ADA. With eAG, patients will see figures that differ greatly from the A1c results they have been receiving. For example, the usual A1c goal of 7% is the same as an eAG of 154 mg/dl. ADA hopes that using eAG will help patients better monitor their long-term glucose management.
A recent ADA recommendation that health professionals begin discussing eAG with patients in diabetes management education comes after a recent study, called ADAG for A1c-derived average glucose, showed a reliable correlation between A1c readings and average blood glucose levels. By comparing the measurement of A1c with the average glucose levels, study investigators were able to derive an equation allowing accurate interpretation of A1c levels as an eAG, according to ADA.
While eAG figures will help patients more directly see the difference between their individual meter readings and how they are doing with their glucose management overall, ADA notes that an eAG value is unlikely to match the average glucose level shown on a meter. That’s because diabetics are more likely to monitor their glucose first thing in the morning or before meals, when their blood glucose levels are low. So the average of these readings on glucose meters is likely to be lower than their eAG, which represents an average of their glucose levels 24 hours a day, including post-meal periods of higher blood glucose when people are less likely to test.
That term, “estimated average glucose (eAG),” refers to the result of a diabetic’s glycated hemoglobin (A1c) test, converted into an average blood glucose level in the units of measure seen on glucose meters. Both the American Diabetes Association (ADA) and the American Association for Clinical Chemistry (AACC) hope that using eAG helps patients and their doctors make the necessary changes to diet and physical activity to improve overall diabetes management.
While AACC has called upon laboratories to express A1c results as eAG, it favors a cautious approach to using this new term and number. In a recently released statement, AACC has asked labs to report eAG along with the A1c results patients are used to seeing. The basis of AACC’s position is what it identifies as the need for more data. “At the current time, there is inadequate data to justify sole reporting of eAG without the A1c result,” the statement notes. In particular, AACC calls for further study of whether it’s appropriate to use eAG in certain ethnic groups, pregnant women, and adolescents.
A1c tests, administered during doctor visits, measure average blood glucose control over the previous two to three months. With results stated in percentage points (i.e., A1c of 7%), A1c has long been an important tool in diabetes management. In general, A1c results indicate how successful a patient has been over a period of time in keeping glucose levels in a healthy range through daily self-testing and adjustments to insulin doses.
Diabetics test blood glucose levels several times a day, often before every meal. The readings from self-monitoring help patients fine-tune insulin doses to maintain their glucose levels within an acceptable range. These results are reported in different units than A1c, mg/dl (i.e., 170 mg/dl). Readings from self-monitoring represent the level of glucose in the blood at that moment in time, but do not give any indication of what glucose levels are at other times of day nor what average levels may be over several weeks as do results from the A1c test.
Like A1c, eAG evaluates a patient’s overall success at controlling glucose levels. However, by converting A1c percentage points to the same units as the meters patients use for daily self-monitoring (mg/dl), eAG results have the added advantage of giving physicians and patients a way to correlate A1c results to the daily readings, says ADA. With eAG, patients will see figures that differ greatly from the A1c results they have been receiving. For example, the usual A1c goal of 7% is the same as an eAG of 154 mg/dl. ADA hopes that using eAG will help patients better monitor their long-term glucose management.
A recent ADA recommendation that health professionals begin discussing eAG with patients in diabetes management education comes after a recent study, called ADAG for A1c-derived average glucose, showed a reliable correlation between A1c readings and average blood glucose levels. By comparing the measurement of A1c with the average glucose levels, study investigators were able to derive an equation allowing accurate interpretation of A1c levels as an eAG, according to ADA.
While eAG figures will help patients more directly see the difference between their individual meter readings and how they are doing with their glucose management overall, ADA notes that an eAG value is unlikely to match the average glucose level shown on a meter. That’s because diabetics are more likely to monitor their glucose first thing in the morning or before meals, when their blood glucose levels are low. So the average of these readings on glucose meters is likely to be lower than their eAG, which represents an average of their glucose levels 24 hours a day, including post-meal periods of higher blood glucose when people are less likely to test.
Thursday, April 02, 2009
Multi-generational living hard on women's hearts
NEW YORK (Reuters Health) - Women, but not men, who live in households with a spouse, children, and parents have double the risk for a coronary event, such as a heart attack or need for heart surgery, as women who live only with a spouse, according to research from Japan.
Stress may play a role in this increased risk, as about a quarter of the women living in a three-generation household or living with a spouse and parent reported high stress. Fewer women were highly stressed when they lived alone, with a spouse, or with a spouse and child, Professor H. Iso and colleagues report in the journal Heart.
Iso, of Osaka University, and colleagues assessed coronary heart disease events and deaths in relation to the living arrangements reported by nearly 91,000 Japanese men and women who were 40 to 69 years old.
Over 11 years of follow up, Iso's team noted no significant impact on CHD incidence among the men in the study.
However, among the women, those living in three-generation households had twice the risk for heart-related events as women living only with a spouse. Moreover, women living with spouses and parents had triple the risk for heart problems compared with women living only with a spouse.
These findings are relevant for Japanese health policy, Iso and colleagues surmise, particularly in light of the increasing female workforce, the declining marriage rate, and the rapid aging of the population in Japan.
Subscribe to:
Posts (Atom)